Association of large-airway lymphocytic bronchitis with bronchiolitis obliterans syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 187, Issue 4, 2013, Pages 417-423

  Greenland, John R ^a,b   Jones, Kirk D ^c   Hays, Steve R ^a   Golden, Jeffrey A ^a   Urisman, Anatoly ^c   Jewell, Nicholas P ^d   Caughey, George H ^a,b   Trivedi, Neil N ^a,b  

^a Department of Medicine ^*  (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bronchiolitis obliterans; Bronchoscopy; Graft rejection; Lung transplantation

Indexed keywords

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHITIS; BRONCHUS BIOPSY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; LYMPHOCYTIC BRONCHITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR;

BIOPSY; BRONCHI; BRONCHIOLITIS OBLITERANS; BRONCHITIS; BRONCHOSCOPY; FEMALE; GRAFT REJECTION; HUMANS; INFLAMMATION; LUNG TRANSPLANTATION; LYMPHOCYTES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYNDROME;

EID: 84873950580     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201206-1025OC     Document Type: Article

References (30)

1. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002;166:440-444.
2. Hayes D Jr. A review of bronchiolitis obliterans syndrome and therapeutic strategies. J Cardiothorac Surg 2011;6:92.
3. Hopkins PM, McNeil K. Evidence for immunosuppression in lung transplantation. Curr Opin Organ Transplant 2008;13:477-483.
4. Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 1998;17:1255-1263.
5. Trulock EP. Management of lung transplant rejection. Chest 1993;103: 1566-1576.
6. Kukafka DS, O'Brien GM, Furukawa S, Criner GJ. Surveillance bronchoscopy in lung transplant recipients. Chest 1997;111:377-381.
7. Hopkins PM, Aboyoun CL, Chhajed PN, Malouf MA, Plit ML, Rainer SP, Glanville AR. Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med 2004;170:1022-1026.
8. Hachem RR, Khalifah AP, Chakinala MM, Yusen RD, Aloush AA, Mohanakumar T, Patterson GA, Trulock EP, Walter MJ. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation 2005;80:1406-1413.
9. Glanville AR, Aboyoun CL, Havryk A, Plit M, Rainer S, Malouf MA. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation. Am J Respir Crit Care Med 2008;177:1033- 1040.
10. Irani S, Gaspert A, Vogt P, Russi EW, Weder W, Speich R, Boehler A. Inflammation patterns in allogeneic and autologous airway tissue of lung transplant recipients. Am J Transplant 2005;5:2456-2463.
11. Xu X, Golden JA, Dolganov G, Jones KD, Donnelly S, Weaver T, Caughey GH. Transcript signatures of lymphocytic bronchitis in lung allograft biopsy specimens. J Heart Lung Transplant 2005;24:1055- 1066.
12. Law L, Zheng L, Orsida B, Levvey B, Oto T, Kotsimbos AT, Snell GI, Williams TJ. Early changes in basement membrane thickness in airway walls post-lung transplantation. J Heart Lung Transplant 2005;24: 1571-1576.
13. Trivedi NN, Caughey GH, Carillo E, Mattucci T, Golden JA, Hays SR. Endobronchial biopsy in lung allograft recipients is more sensitive than transbronchial biopsy in detecting lymphocytic bronchitis/ bronchiolitis, a risk factor for bronchiolitis obliterans syndrome. Presented at the American Thoracic Society International Conference.May 16-21, 2008, Toronto, Canada.
14. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21: 297-310.
15. Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, Glanville A, Gould FK, Magro C, Marboe CC, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007;26:1229- 1242.
16. Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: Twentyeighth Adult Lung and Heart-Lung Transplant Report-2011. J Heart Lung Transplant 2011;30:1104-1122.
17. Arcasoy SM, Berry G, Marboe CC, Tazelaar HD, Zamora MR, Wolters HJ, Fang KC, Keshavjee S. Pathologic interpretation of transbronchial biopsy for acute rejection of lung allograft is highly variable. Am J Transplant 2011;11:320-328.
18. Chakinala MM, Ritter J, Gage BF, Aloush AA, Hachem RH, Lynch JP, Patterson GA, Trulock EP. Reliability for grading acute rejection and airway inflammation after lung transplantation. J Heart Lung Transplant 2005;24:652-657.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
20. Lama VN, Murray S, Mumford JA, Flaherty KR, Chang A, Toews GB, Peters-Golden M, Martinez FJ. Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients. Am J Respir Crit Care Med 2005;172:379-383.
21. Hachem RR, Chakinala MM, Yusen RD, Lynch JP, Aloush AA, Patterson GA, Trulock EP. The predictive value of bronchiolitis obliterans syndrome stage 0-p. Am J Respir Crit Care Med 2004;169: 468-472.
22. Swanson SJ, Mentzer SJ, Reilly JJ, Bueno R, Lukanich JM, Jaklitsch MT, Kobzik L, Ingenito EP, Fuhlbrigge A, Donovan C, et al. Surveillance transbronchial lung biopsies: implication for survival after lung transplantation. J Thorac Cardiovasc Surg 2000;119:27-38.
23. Valentine VG, Taylor DE, Dhillon GS, Knower MT, McFadden PM, Fuchs DM, Kantrow SP. Success of lung transplantation without surveillance bronchoscopy. J Heart Lung Transplant 2002;21:319-326.
24. Valentine VG, Gupta MR, Weill D, Lombard GA, LaPlace SG, Seoane L, Taylor DE, Dhillon GS. Single-institution study evaluating the utility of surveillance bronchoscopy after lung transplantation. J Heart Lung Transplant 2009;28:14-20.
25. Sandrini A, Glanville AR. The controversial role of surveillance bronchoscopy after lung transplantation. Curr Opin Organ Transplant 2009;14:494-498.
26. McWilliams TJ, Williams TJ, Whitford HM, Snell GI. Surveillance bronchoscopy in lung transplant recipients: risk versus benefit. J Heart Lung Transplant 2008;27:1203-1209.
27. Diette GB, Wiener CM, White P Jr. The higher risk of bleeding in lung transplant recipients from bronchoscopy is independent of traditional bleeding risks: results of a prospective cohort study. Chest 1999;115: 397-402.
28. Uyama T, Winter JB, Groen G, Wildevuur CR, Monden Y, Prop J. Late airway changes caused by chronic rejection in rat lung allografts. Transplantation 1992;54:809-812.
29. Kalb TH, Chuang MT, Marom Z, Mayer L. Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. Am J Respir Cell Mol Biol 1991;4:320-329.
30. Taylor PM, Rose ML, Yacoub MH. Expression of MHC antigens in normal human lungs and transplanted lungs with obliterative bronchiolitis. Transplantation 1989;48:506-510.